IMRX vs PEG · $124.2M cap vs P/E 18, rev $10.29B
Immuneering Corp (IMRX) versus Public Service Enterprise Group Inc (PEG) — a side-by-side from cached financials, not a winner call.
Immuneering Corp (IMRX) is a biotechnology company listed on US.
Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.
Latest reported IMRX revenue for 2023-12-31 was $0. Net income was -$53.5M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. IMRX currently screens at market cap $124.2M.
Latest reported PEG revenue for 2024-12-31 was $10.29B. Net income was $1.77B. Revenue was down 8.4% from 2023-12-31 to 2024-12-31. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
IMRX currently screens at market cap $124.2M. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
Not investment advice. Open the IMRX and PEG stock pages for the full models.
Not investment advice.